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Tbx1 has been implicated as a candidate gene responsible for defective pharyngeal arch remodeling in DiGeorge/Velocardiofacial
syndrome. Tbx1+/ mice mimic aspects of the DiGeorge phenotype with variable penetrance, and null mice display severe pharyngeal
hypoplasia. Here, we identify enhancer elements in the Tbx1 gene that are conserved through evolution and mediate tissue-specific expression.
We describe the generation of transgenic mice that utilize these enhancer elements to direct Cre recombinase expression in endogenous Tbx1
expression domains. We use these Tbx1-Cre mice to fate map Tbx1-expressing precursors and identify broad regions of mesoderm, including
early cardiac mesoderm, which are derived from Tbx1-expressing cells. We test the hypothesis that fibroblast growth factor 8 (Fgf8) functions
downstream of Tbx1 by performing tissue-specific inactivation of Fgf8 using Tbx1-Cre mice. Resulting newborn mice display DiGeorge-like
congenital cardiovascular defects that involve the outflow tract of the heart. Vascular smooth muscle differentiation in the great vessels is
disrupted. This data is consistent with a model in which Tbx1 induces Fgf8 expression in the pharyngeal endoderm, which is subsequently
required for normal cardiovascular morphogenesis and smooth muscle differentiation in the aorta and pulmonary artery.
D 2003 Elsevier Inc. All rights reserved.Keywords: Fgf8; Tbx1-Cre mice; DiGeorge syndrome
Introduction metric arteries that are remodeled to form the matureThe pharyngeal arches are transient embryonic structures
that give rise to the ventral regions of the head and neck.
The pharyngeal arches arise as ventrolateral outpouches.
Each arch consists of a mesodermal core covered with an
outer layer of ectoderm and an inner layer of endoderm. The
arches are invaded by neural crest cells that remodel the
primitive structure and form mature tissues including bone,
nerve, connective tissue, and smooth muscle. The para-
thyroids and thymus are derived from the endoderm of the
pharyngeal pouches with contributions from neural crest
(Graham, 2001; Graham and Smith, 2001). Contained
within the arches are a series of initially bilaterally sym-0012-1606/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
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eling of the pharyngeal arches and associated arch arteries
are a result of complex molecular interactions between the
mesodermally derived arch core mesenchyme, ectoderm,
endoderm, and neural crest cells (Hiruma et al., 2002).
Observations of pharyngeal patterning abnormalities sec-
ondary to a specific genetic mutation might reflect defects in
ectoderm, mesoderm, endoderm, or neural crest. Defects
may reflect a primary defect in a given tissue layer or
defective signaling between tissue types.
DiGeorge syndrome is a common human haploinsuffi-
cient disorder affecting pharyngeal arch development and
patterning. DiGeorge syndrome is characterized by de-
creased or absent parathyroid and thymus, craniofacial
abnormalities, and conotruncal and aortic arch cardiac
defects (Epstein, 2001; Goldmuntz and Emanuel, 1997).
The T-box transcription factor TBX1 has recently been
described as a candidate gene for DiGeorge syndrome.
Tbx1 Fragment 1 Forward:
GGCTCGAGACGGGCACCAGGCAGTCCTGTG
Tbx1 Fragment 1 Reverse:
CGGGATCCTTCACTGCCTATGTTACCTCTTTTAATGTGGC
Fragment 1: 3547 bp
Tbx1 Fragment 2 Forward:
CCGCTCGAGCGCGGATCCACACACTGTGGGGTGGCTTCTG
Tbx1 Fragment 2 Reverse:
CAGCAGAACAGGGTATAGAGGCTCTGTGGG
Fragment 2: 772 bp
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like cardiovascular, thymic, and parathyroid defects in
embryos heterozygous for the mutation. Tbx1 nulls display
a more complete pharyngeal arch phenotype including
severe hypoplasia of the thymus and parathyroid, craniofa-
cial and skeletal abnormalities, and cleft palate in addition to
cardiovascular malformations (Jerome and Papaioannou,
2001; Lindsay et al., 2001; Merscher et al., 2001).
Tbx1 is a member of the T-box family of transcription
factors. The expression pattern of Tbx1 is consistent with a
role in pharyngeal arch and pouch remodeling (Garvey et
al., 1996). As the pharyngeal arches are forming between E9
and 11 in the mouse, Tbx1 is expressed in the head
mesenchyme and mesenchyme dorsal to the pharynx as
well as the mesenchymal cores of pharyngeal arches 1–3.
Tbx1 is expressed in the epithelium of the otic vesicle and in
the epithelium of the endodermal pouches (Garvey et al.,
1996). Endodermal expression in the pharyngeal pouches is
temporally regulated such that expression is first noted in
pouch 1, followed by sequential expression in more caudal
pouches (Vitelli et al., 2002a). Expression is also observed
in the sclerotome of the developing somite, consistent with
the skeletal defects seen in Tbx1 null mice (Jerome and
Papaioannou, 2001).
Tbx1 affects developmental processes in both cell auton-
omous and cell nonautonomous fashions. This bimodal
activity of Tbx1 is evident in the phenotype of DiGeorge
syndrome and in targeted Tbx1 mice. In the pharyngeal
endoderm, Tbx1 is presumed to act cell autonomously to
directly regulate the development of the thymic and para-
thyroid precursor cells in which it is expressed (Jerome and
Papaioannou, 2001; Merscher et al., 2001). The function of
Tbx1 in regulating development of other pharyngeal struc-
tures has been less clear. While Tbx1 is broadly expressed in
mesodermal tissues including the head mesenchyme and the
mesenchymal cores of the pharyngeal arches, these areas are
heavily invested with and remodeled by neural crest cells
that give rise to the bulk of the mature structures (Graham,
2001; Graham and Smith, 2001). Results from our lab and
others have shown that Tbx1 is not expressed in the neural
tube or neural crest cells (Kochilas et al., 2002; Vitelli et al.,
2002a). Thus, a primary role of Tbx1 in pharyngeal devel-
opment may be to regulate expression of secreted signaling
factors required for migration, differentiation, and mainte-
nance of neural crest cells.
Recent reports have suggested that Tbx1 expression in
pharyngeal pouch endoderm regulates expression of secret-
ed Fgf8 (Abu-Issa et al., 2002; Frank et al., 2002; Kochilas
et al., 2002; Vitelli et al., 2002b). In Tbx1 nulls, Fgf8 is
down-regulated in Tbx1 expression domains such as the
pharyngeal endoderm, while Fgf8 expression is unaltered in
surface ectoderm that does not normally express Tbx1. Fgf8
hypomorphic mice display defects in aortic arch patterning
similar to those seen in Tbx1-deficient animals. Defective
aortic arch patterning in the Fgf8 hypomorphs may be due
to inappropriate cell death or differentiation of the invadingneural crest cells caused by a loss of Fgf8 from the
underlying endoderm (Abu-Issa et al., 2002 and Frank et
al., 2002). It remains unclear whether Fgfs have direct long-
range effects on cardiac neural crest cells, or if they activate
secondary signaling cascades within the pharyngeal mesen-
chyme, which subsequently signal to the neural crest.
Patterning of mesenchyme by an adjacent layer of epithe-
lium is a common mechanism utilized in the formation of
many tissues throughout embryogenesis (Johnson et al.,
1994).
To better understand the role of Tbx1 and downstream
signaling pathways in aortic arch patterning, we have
analyzed the cis-control elements regulating Tbx1 gene
expression in murine embryos and we have identified
separable regions regulating gene expression. We have
utilized Tbx1 regulatory elements to generate transgenic
mice expressing Cre-recombinase in the Tbx1 expression
domain. Fate-mapping studies utilizing these mice provide
new insights into the extent of the contributions of cells of
the Tbx1 lineage to mature structures. We demonstrate that
targeted inactivation of Fgf8 in the Tbx1 domains results in
a spectrum of cardiovascular defects reminiscent of
DiGeorge syndrome, confirming a role for Fgf8 in cardio-
vascular patterning, demonstrating that FGF8 production
fromTbx1 expressing cells is required for normal cardio-
vascular patterning.Materials and methods
Transgenic analysis
Tbx1 cDNA sequences were used to identify human and
mouse genomic sequences in the NCBI database. Regions
of sequence homology were identified by direct human–
mouse sequence comparison. Fragments were amplified by
PCR from SV129 mouse genomic DNA using LA-Taq
DNA polymerase (TAKARA). Fragments were subcloned
into a modified pBluescript vector containing a lacZ-
coding region and SV40 poly A using a subcloning
strategy in which the 5V primer incorporated XhoI and
BamHI restriction sites while the 3V primer incorporated a
BglII site. Fragments are defined in Fig. 1. The somite
enhancer was identified by serial deletion analysis and
represents the 5Vmost 207 bp of enhancer fragment 1, a
Tbx1 Fragment 3 Forward:
CCGCTCGAGCGCGGATCCTGACAGTACCTGGGGTAAGGGA
Tbx1 Fragment 3 Reverse:
CGAAGATCTCCCAGGTCACCAGGGCCCCCTGCGGTCTAGA
Fragment 3: 222 bp
Tbx1 Proximal Forward:
CCGCTCGAGCGCGGATCCAGCGACGGTGCTGGGTGCAGCC
Tbx1 Proximal Reverse:
GGAGATCTGGTAGCCGGCGAAGTTTCGCCC
Proximal: 3129 bp
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sequences (Fig. 1A).
Enhancer-lacZ constructs were purified by restriction
digestion and gel purification. Pronuclear injections for
generation of transgenic animals were performed by the
University of Pennsylvania mouse transgenic core or the
Cardiology Division mouse transgenic core. Expression
patterns were assayed following overnight incubation in
X-gal (5V-bromo-4-chloro-3-indolyl-h-D-galactopyranoside).
Protocols are available online at http://www.uphs.upenn.
edu/mcrc. To establish stable lines, the 7.6-kb Tbx1 se-
quence used to produce Tbx1-lacZ construct A (Fig. 1B)
was subcloned into either lacZ or Cre-recombinase expres-
sion vectors.
Generation of Tbx1-CreDR26R embryos
To lineage trace Tbx1-Cre expressing cells, potential
Tbx1-Cre founders were identified by PCR and mated to
homozygous R26R reporter mice (Soriano, 1999). Embry-
onic day 0.5 was defined as noon on the day of vagina plug.
Six independent Tbx1-Cre founders exhibit identical stain-
ing patterns consistent with the known expression domain of
Tbx1. Embryos were fixed in 2% PFA for 2 h and stained for
h-galactosidase activity at 37jC. Images presented are
representative of data obtained for all founders.
Generation of Tbx1-CreDFgf8flox/ embryos
To generate Tbx1-domain tissue specific deletion of Fgf8,
we utilized an allelic series of targeted mutations at the Fgf8
gene locus (Meyers et al., 1998). One parent in the mating is
homozygous for an Fgf8 allele in which exons 4 and 5 are
flanked by loxP sites (Fgf8flox/flox). The Fgf8 null allele was
generated by germline Cre-recombinase-mediated excision
of exons 4 and 5 from the loxP allele. Fgf8 heterozygotes
were mated to Tbx1-Cre founders to generate Tbx1-
CreDFgf8+/ . Pups from appropriate intercrosses were
harvested between 9.5 and 18.5 dpc or at birth and fixed
24–48 h in 4% paraformaldehyde.
Immunohistochemistry and histology
Stained and unstained tissues or embryos were dehy-
drated through graded alcohol series, embedded in paraffin,and sectioned at 6–10 AM. Sections from embryos stained
for h-galactosidase expression were counterstained with
eosin. Neonatal heart-lung sections from Tbx1-CreD
Fgf8flox/  embryos were stained with hemotoxylin and
eosin to a-actin expression (http://www.uphs.upenn.edu/
mcrc). In situ hybridization was performed as described
(Wawersik and Epstein, 2000).
Genotyping
Genotyping was performed by PCR on DNA obtained
from embryonic membranes or embryo tails. Primers, PCR
conditions and genotyping protocols are available online at
http://www.uphs.upenn.edu/mcrc.Results
Identification of conserved regions in the Tbx1 upstream
genomic region between human and mouse
Traditional enhancer analysis requires subcloning of
large segments of genomic DNA and an iterative deletion
scheme to identify individual enhancer regions. We chose
instead to take advantage of the power of multispecies
comparative sequence analysis to identify noncoding
regions of homology. Using standard database techniques,
we compared approximately 20 kb of DNA sequence
upstream from the Tbx1 start methionine between human
and mouse by NCBI Blast2 (Altschul et al., 1997). We
identified more than 10 regions of homology that ranged in
size from approximately 50–250 bp (Fig. 1A). To assess the
potential in vivo function of these elements, we cloned
genomic fragments containing regions of conservation up-
stream of a lacZ reporter gene (Fig. 1B) and made F0
transient transgenic mice. These homologous regions were
grouped to facilitate PCR based cloning of only four
genomic fragments (Fig. 1A). Subsequent analysis of the
same sequences with the VISTA sequence comparison
program confirmed our original analysis and identified
additional regions of somewhat lesser homology that were
not included in our transgenic analysis (Fig. 1A) (Dubchak
et al., 2000; Mayor et al., 2000). Comparative sequence
analysis allowed us to eliminate nearly two thirds of the 20
kb of DNA examined before generating any transgenic
animals (Dubchak et al., 2000; Mayor et al., 2000).
Within the proximal 3.1 kb of sequence upstream of the
start ATG of Tbx1, significant regions are conserved be-
tween mouse and human; this region contains the minimal
promoter and transcriptional start site(s) (Fig. 1B). Howev-
er, this region was insufficient to direct expression of lacZ in
eight transient transgenic embryos (Fig. 1, construct H).
However, addition of three distinct regions that together
contained most of the regions of significant homology
within the proximal 16 kb of upstream sequence (Figs.
1A,B, construct A) was sufficient to recapitulate the endog-
Fig. 1. Tbx1 genomic comparisons and enhancer constructs. (A) VISTA alignment of mouse and human Tbx1 genomic sequences. The X-axis is human
sequence in base pairs from the start ATG. The Y-axis is percent identity with the corresponding mouse sequence. Pink elements represent regions of greater
than 100 bp of >75% conserved sequence. The relative positions of subcloned fragments are indicated by black bars. (B) Stick diagrams indicate relative
positions of fragments from mouse genomic sequence used for production of transgenic mice. Expression domains for each construct are indicated. Below, the
position of a recently described 1.1-kb enhancer that drives expression in head mesenchyme and pharyngeal endoderm (Yamagishi et al., 2003) is indicated.
The relative position of the conserved forkhead transcription factor binding site reported by Yamagishi et al. and its sequence are also shown.
Fig. 2. Expression of Tbx1-lacZ construct A (depicted in Fig. 1B) and endogenous Tbx1 at E10.5. (A, B) Expression is observed in mesenchyme (mes), otic
vesicle (ot), sclerotome (sc), heart (ht), and pharyngeal mesenchyme (ph, white arrowhead). (C, D) Eosin-stained saggital sections through the same embryo in
A. Note endoderm expression in (D), black arrows. (E, F) Analysis of Tbx1 expression by radioactive in situ hybridization in E10.5 saggital sections. Note
expression in mesenchyme (mes), otic vesicle (ot), endoderm (end), and sclerotome (sc) similar to expression in the transgenic embryo in C, D.
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dently derived embryos, and in two subsequently developed
stable transgenic lines, expression was evident in the head
mesenchyme (Figs. 2A–D), the posterior region of the otic
vesicle epithelium (Fig. 2C), the sclerotome (Figs. 2A–C),
and pharyngeal endoderm (Fig. 2D). Expression was present
in the core mesenchyme of the pharyngeal arches and in a
subpopulation of myocardial cells in the heart (Figs. 2B,C).
Each of these domains of expression represents endogenous
regions of Tbx1 expression as demonstrated by our labora-
tory (Figs. 2E,F) and others (Garg et al., 2001; Garvey et al.,
1996). Hence, critical sequences required for most or all of
Tbx1 expression reside within regions of upstream homol-
ogy (fragments 1–3, Fig. 1).Fig. 3. Identification of a somite-specific enhancer element. (A) Somite (so)-specifi
the somite element is deleted from Fragment 1 yielding construct C. Expression i
tract (ot). (C) Cross section of Tbx1-lacZ construct E embryo showing h-gal expr
(ep). h-gal expression colocalized with myoD (D). Higher power shows nuclear e
(blue) in the same cells (E).We constructed serial deletions of the 7.6-kb transgenic
expression construct A by removing regions of sequence
homology, as outlined in Fig. 1. Removal of the most
upstream region (fragment 1, resulting in construct F, Fig.
1B) results in the complete loss of all expression at E10.5
(14 genotype positive embryos examined). Similarly, con-
structs containing only fragment 3 and the proximal element
(construct G, Fig. 1B) failed to drive transgene expression in
10 transgenic embryos. A 207-bp element at the 5Vend of
fragment 1 is sufficient to drive reporter expression in the
somite (construct B, and Fig. 3A). Deletion of this somite
element from construct A (producing construct C) elimi-
nates somite expression but leaves other expression domains
unaffected, thus demonstrating that this element is necessaryc expression obtained with construct B. (B) Loss of somite expression when
s maintained in the pharyngeal core mesenchyme (ph) and cardiac outflow
ession in the myotome (myo) but not in the epithelial portion of the somite
xpression of myoD (brown) and cytoplasmic expression of h-galactosidase
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expression of Tbx1-lacZ was evident in the myotomal
region of the somite, but not in the epithelial layer (Fig.
3C). Expression in myotomal cells was confirmed by
costaining with a myoD antibody (Figs. 3D,E) and with
an antibody to myosin (MF20, not shown).
Transgenic construct D, which utilizes only Fragment 1
attached to the Tbx1 proximal element, recapitulates the
entire Tbx1 expression domain. This was also the case
when Fragment 1 was attached to a heterologous HSP
promoter (construct E). Thus, all of the sequences required
for regulation of Tbx1 expression are contained within the
3.5-kb Fragment 1. Previous reports have demonstrated
that Tbx1 expression in pharyngeal mesenchyme and
endoderm is genetically downstream of Sonic hedgehog
(Shh) signaling (Garg et al., 2001). Consistent with these
results, we observed down-regulation of Tbx1 transgene
expression in Shh null embryos (Chiang et al., 1996) and
ectopic Tbx1 expression in the periotic mesenchyme in a
model of Shh overexpression (ShhP1) (Riccomagno et al.,
2002) (data not shown). Shh may activate Tbx1 indirectly
by inducing expression of forkhead transcription factors
(Yamagishi et al., 2003). A recent report demonstrated that
sequences containing forkhead transcription factor binding
sites, located at the 3Vend of our Fragment 1 (Fig. 1B), are
responsible for expression in head mesenchyme and pha-
ryngeal endoderm (but not pharyngeal mesoderm) (Yama-
gishi et al., 2003). Our results are consistent with this
observation, although we have not yet directly confirmed
the importance of the reported forkhead-binding site. Spe-
cific sequences required for expression in pharyngeal
mesoderm and otic vesicle, while contained within Frag-
ment 1, remain to be elucidated.
Characterization of transgenic mice expressing Cre
recombinase in the Tbx1 expression domain and
fate-mapping of Tbx1 descendents
We used the Tbx1 regulatory regions to create transgenic
mice expressing Cre recombinase in Tbx1 expression
domains. We included all of the conserved regions depicted
in Fig. 1B construct A. A total of six independent Cre-
expressing transgenic lines were expanded and character-
ized. All six lines yielded consistent results, suggesting
faithful expression of Tbx1-Cre in endogenous domains,
unrelated to the site of transgene insertion. We refer to these
as Tbx1-Cre mice.
We crossed Tbx1-Cre mice with R26R reporter mice that
express lacZ constitutively in cells that express Cre recom-
binase (Soriano, 1999). Hence, the descendents of Cre-
expressing cells can be identified by assaying for h-
galactosidase activity even after Cre expression has itself
subsided. We examined Tbx1-CreDR26R embryos between
E7.5 and birth (Fig. 4). Unexpectedly, at E7.5, we observed
labeled cells in a pattern similar to the cardiac crescent
where myocardial cells arise (Fig. 4A). By E8.5, labeledcells were identified in the pharyngeal region and head
mesenchyme (Fig. 4B) though the heart tube was unla-
beled. By E9.0–E9.5, h-galactosidase-expressing cells
were seen in the outflow tract of the heart and the
primordial of the right ventricle, but labeled cells were
not seen in the left ventricle (Figs. 4C–E). Tbx1 previously
has been shown to be expressed by a few cardiac myocytes
in the outflow tract of the heart (Vitelli et al., 2002a), and
we observed a similar expression pattern in our Tbx1-lacZ
embryos, but many cardiac myocytes in the heart at E9.5
do not express Tbx1. This indicates that cardiac myocytes
in the outflow tract and right ventricle derive from Tbx1-
expressing precursors that have subsequently extinguished
Tbx1 expression.
By E10.5, a few labeled cells were seen crossing the
interventricular sulcus (arrow, Fig. 4G) and significant
portions of the left ventricle were labeled by E14.5 (Fig.
4H) and in the adult heart (Fig. 4I) in addition to almost the
entire right ventricle. Throughout development, labeled cells
were also identified in pharyngeal endoderm and derivatives
including the thymus (not shown). The pattern of expression
during development of the heart, shown in Fig. 4, is
consistent with expression of Tbx1 by progenitors of the
recently described secondary (or anterior) heart field (Kelly
and Buckingham, 2002; Kelly et al., 2001; Waldo et al.,
2001).
We examined Tbx1 gene expression by in situ hybrid-
ization at E7.5 (Fig. 5A) and E8.5 (Fig. 5C). At E7.5, Tbx1
expression is evident in broad regions of the lateral plate
mesoderm including cardiogenic regions (Fig. 5A). Expres-
sion partially overlaps with that of Nkx2.5, an early marker
of cardiogenic cells (Fig. 5B). Tbx1 appears to be expressed
in a subset of cardiogenic precursors, consistent with our
Tbx1-Cre fate-mapping experiments. By E8.5, endoge-
nousTbx1 expression (Fig. 5C) is weak in the heart region,
while Nkx2.5 is abundantly expressed in the myocardium
(Fig. 5D). To confirm that our Tbx1-Cre mice were express-
ing Cre recombinase is the same progenitors as those that
express Tbx1, we performed in situ hybridization using
adjacent sections from an E7.25 Tbx1-Cre embryo with
Tbx1 and Cre riboprobes (Figs. 5E,F). Expression of Tbx1
and Cre were evident in the same population of early
mesoderm, indicating that Cre expression accurately reca-
pitulates endogenous expression of Tbx1 in this tissue.
Taken together, these results indicate that Tbx1 is expressed
very early and transiently in some cardiac progenitors that
later give rise to the outflow tract myocardium, large
portions of the right ventricle, and some portions of the left
ventricle.
A subpopulation of vascular smooth muscle is derived from
Tbx1-expressing cells
In all of the Tbx1-Cre adult mice examined, we noted
broad expression in the vasculature. Histological sections
indicated that some vascular smooth muscle is derived from
Fig. 4. Fate mapping of Tbx1-expressing cells. (A) At E7.5, expression of h-galactosidase is evident in the area of the cardiac crescent (cc) in Tbx1-CreDR26R
embryos. (B) At E8.5, expression is strong in the head mesenchyme but little expression is seen in the heart (ht). (C) At E9.0, expression is evident in the head
mesenchyme, otic vesicle, and pharyngeal arch mesenchyme. Expression is also seen in the outflow tract of the heart. (D) By E9.5, expression has extended
into the right ventricle. (E) Higher magnification of an E9.5 heart demonstrates restriction of blue cells to the right ventricle (rv) and conotruncus. (F) Right
lateral view of an embryo at E10.5 showing strong expression in head mesenchyme and heart. Expression in the right atria is weak and spotty. (G) Left lateral
high magnification view of the heart of the embryo in F. Strong expression is observed in the right ventricle and patches of expressing cells (white arrowhead)
can be observed crossing the interventricular boundary into the left ventricle (lv). (H) At E14.5, the right ventricle appears to be almost completely derived from
Tbx1 descendants. Staining crosses the boundary between the right and left ventricles (dotted line) and significant regions of the left ventricle are stained. (I)
Staining of the heart from an adult Tbx1-CreDR26R mouse reveals extensive contribution from Cre-expressing progenitors throughout the myocardium with
more extensive contribution to the right ventricle and atria compared with the left ventricle. h-galactosidase expression is detected in the ascending aorta (AAo)
and descending aorta (DAo) but is absent from the aortic arch (between red arrowheads), the right common carotid (RCC), and left common carotid (LCC)
arteries. A section through the descending aorta stained for smooth muscle a-actin (brown) demonstrates coexpression of this smooth muscle marker with h-
galactosidase (I inset).
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labeled smooth muscle was seen in the great vessels
including the ascending aorta and the descending aorta
beyond the ductus arteriosus. However, the aortic arch and
the carotid arteries were not labeled (Fig. 4I). We have
previously shown that smooth muscle in the aortic arch and
carotid arteries derives from neural crest (Li et al., 2000).
Hence, vascular smooth muscle is derived from lateral plate
mesoderm, identified by Tbx1-Cre expression, and alsofrom neural crest, identified by Wnt1-Cre (Jiang et al.,
2000) and Pax3-Cre expression (Li et al., 2000). Taken
together, these results suggest that Tbx1 may play early roles
in cardiac and smooth muscle development.
Targeted inactivation of Fgf8 in Tbx1 expression domains
Fgf8 signaling has recently been reported as a critical
mediator of aortic arch development downstream of Tbx1
Fig. 5. Early cardiogenic expression of Tbx1. Tbx1 expression was assessed by radioactive in situ hybridization at E7.5 (A) and E8.5 (C). Tbx1 is expressed in
the cardiac crescent (cc) at E7.5 (A), but expression is down-regulated in the heart tube (ht) at E8.5 (C). Early expression is also noted in the head mesenchyme
(red arrows A). Nkx2.5 is expressed in the cardiac crescent at E7.5 (B) and expression persists in the heart tube (ht) and foregut (fg) at E8.5 (D). Adjacent
sections (E, F) of an E7.25 Tbx1-Cre embryo reveals expression of Tbx1 (E) and Cre (F) in a subdomain of early mesoderm (arrows, E, F).
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2002b). To perform tissue specific inactivation of Fgf8 in
the Tbx1 expression domain, we took advantage of previ-
ously described Fgf8 null (Fgf8 /) and loxP (Fgf8flox)
alleles (Meyers et al., 1998). In the loxP allele, Fgf8 exons 4
and 5 are flanked by loxP sites. Cre-recombinase mediated
excision generates a null allele in Cre-expressing tissues.
Mice heterozygous for the Fgf8 null allele were mated to
Tbx1-Cre founders to generate compound heterozygotes
(Tbx1-CreDFgf8+/). Tbx1-CreDFgf8+/ mice were mated
to mice homozygous for an Fgf8 loxP flanked allele
(Fgf8flox/flox). One quarter of the progeny from this mating
are expected to be Tbx1-CreDFgf8flox/ . Following Cre-
mediated recombination at the loxP sites, these embryos are
Fgf8 null in the Tbx1-Cre expression domain.
To confirm specific loss of Fgf8 signal in the Tbx1
expression domain, we performed radioactive in situ hy-bridization on E10.5 wild type and Tbx1-CreDFgf8flox/ 
embryo sections. Fgf8 signal is greatly reduced in pharyn-
geal endoderm of Tbx1-CreDFgf8flox/  embryos (Fig. 6B
arrows, en) compared to a wild-type littermate (Fig. 6A).
Fgf8 expression is unaffected in the first arch ectoderm
where Tbx1 is not expressed (Figs. 6A,B white arrowhead,
ec). These results confirm that Tbx1-Cre is functional within
the normal Tbx1 expression domain, and that loss of Fgf8
signal is tissue-specific.
We examined litters derived from Tbx1-CreDFgf8+/
and Fgf8flox/flox crosses between E9.5 and birth. Between
E9.5 and E15.5, we found the expected number of Tbx1-
CreDFgf8flox/ embryos (27/115, 23.5%). By E18.5, we
found an occasional nonviable Tbx1-CreDFgf8flox/  em-
bryo, and at birth we identified numerous cyanotic Tbx1-
CreDFgf8flox/ pups with irregular gasping breathing pat-
terns that succumbed shortly after birth. At P1, we identified
Fig. 6. Fgf8 expression in Tbx1-CreDFgf8flox/ embryos. (A) Fgf8 expression is observed in both endoderm (en) and ectoderm (ec) at E10.5 in wild-type
embryos. (B) Fgf8 expression is lost in the endodermal domain, but maintained in ectoderm in Tbx1-CreDFgf8flox/ embryos.
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(9% vs. 25% expected) indicating significant peri-natal
lethality. Additionally, Tbx1-CreDFgf8flox/  pups were dis-
tinguishable following thoracotomy by reduced and/or sin-
gle lobed thymus. Reduced thymus is also seen in Fgf8
hypomorphs and is consistent with removal of Fgf8 in the
pharyngeal endoderm. However, the gross Tbx1-CreD
Fgf8flox/  phenotype was distinct from Fgf8 hypomorphs,
which display craniofacial defects (Abu-Issa et al., 2002;
Frank et al., 2002), and from Fgf8 nulls, which are early
embryonic lethal (Meyers et al., 1998).
Tbx1-CreDFgf8flox/ embryos and newborn pups dis-
played cardiovascular patterning defects involving the out-
flow tract and proximal great vessels. These defects
included malformations consistent with persistent truncus
arteriosus, double outlet right ventricle, transposition of the
great arteries, Tetrology of Fallot, atrial and ventricular
septal defects and duplicated internal carotid arteries. Impor-
tantly, however, we never observed interruption of the aortic
arch, right-sided aortic arch, or retro-esophageal right sub-
clavian artery. This class of cardiovascular defect involves
predominantly the aortic arch arteries without affecting the
outflow tract of the heart, and are commonly seen in
Tbx1 + / embryos, Fgf8 hypomorphs, and in DiGeorge
syndrome. Hence, inactivation of Fgf8 in the Tbx1 expres-
sion domain recapitulates some, but not all, of the cardio-
vascular defects related to Tbx1 deficiency.
Normal great vessel morphology is displayed in Fig. 7A.
The aorta (Ao) is dorsal to the pulmonary artery and the
proximal arch elevates to the right. Cardiovascular defects
observed in Tbx1-CreDFgf8flox/  animals include defects of
conotruncal septation and malpositioning of the proximal
great vessels. An example of malrotation of the great arteries
is shown in Fig. 7B. In this animal, the aorta is positionedventrally in a side-by-side presentation with the pulmonary
artery (PA). The pulmonary artery overrides the left ventri-
cle (Fig. 7F). Another Tbx1-CreDFgf8flox/ animal pre-
sented with transposition (Fig. 7C). In this individual, the
aorta is ventral to the pulmonary artery (Fig. 7C). Hemo-
toxylin and eosin (H&E) staining of sections confirms an
inappropriate ventral position of the aorta, and demonstrates
that the aorta is in continuity with both ventricles through a
large aortico-pulmonary window (AP, Fig. 7G). Several
Tbx1-CreDFgf8flox/  pups presented with atrial septal
defects (ASD, Fig. 7I) and membranous ventricular septal
defects (VSD, Fig. 7J). One severely affected animal pre-
sented with a Tetrology of Fallot-like phenotype (Figs.
7D,H). This pup had a VSD and severe pulmonary atresia
with no apparent pulmonary trunk arising from the right
ventricle. The pulmonary arteries arose retrograde from the
ductus arteriosus (DA-PA, Fig. 7D). This animal also
exhibited a large arterial dissection filled with thrombus
(Fig. 7H black arrows and Fig. 7L asterisk). The dissection
can clearly be seen in Panel 7L underlying the endothelial
layer that lines the aortic lumen.
Aortic dissection suggests a weakness of the arterial wall.
H&E staining revealed morphological abnormalities of the
arterial wall in Tbx1-CreDFgf8flox/  mice (black arrows,
Fig. 7L) compared to wild type (Fig. 7K). The muscular
wall was of variable thickness and lacked the striated
structural appearance of normal arterial smooth muscle.
This observation was confirmed by smooth muscle a-actin
staining (SMA). Some smooth muscle staining is observed
in the aortic wall of affected individuals (Fig. 7N). How-
ever, SMA expression is not observed in the stereotypic
striated layers expected for mature arterial smooth muscle as
seen in wild-type aorta (Fig. 7M). Defective smooth muscle
differentiation was a consistent finding in most Tbx1-
Fig. 7. Congenital heart disease in Tbx1-CreDFgf8flox/ mice. (A) Wild-type newborn heart after removal of the atria to reveal the outflow tract, aorta (Ao),
and pulmonary artery (PA). (B–D) Mutant embryos with malrotation (B), transposition of the great arteries (TGA) (C), and absent proximal pulmonary artery
(D). In D, the pulmonary artery fills retrograde from the ductus arteriosus (DA–PA). The right common carotid artery is duplicated (RCCs). (E) H&E
transverse section of a wild-type heart at the level of the pulmonary valve. (F) Transverse section of the heart shown in B showing overriding pulmonary artery.
(G) Section of the heart shown in C revealing a large aortico-pulmonary window (AP) and the pulmonary artery dorsal to the aorta consistent with TGA. (H)
Section of the heart in D showing absence of the proximal pulmonary artery. (Arrows indicate a large clot-filled dissection of the arterial wall). (I) A
representative section from a Tbx1-CreDFgf8flox/ animal exhibiting a large atrial septal defect (ASD). (J) An example of ventricular septal defect in Tbx1-
CreDFgf8flox/. (K) H&E section of the aortic arch in wild-type newborn. (L) Aortic arch of the heart shown in D. Note the large dissection (*) lined by
endothelium, and the thin arterial wall (arrows). (M) Smooth muscle a-actin (SMA, brown) stained wild-type aorta. (N) SMA-stained aorta from heart
shown in D. Note low levels of SMA expression and lack of normal smooth muscle architecture. (O) SMA-stained esophagus of wild-type newborn. (P)
SMA-stained esophagus of affected newborn.
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muscle differentiation is also observed in the esophagus
(Figs. 7O,P). SMA expression is greatly reduced (Fig. 7P)
compared to wild type (Fig. 7O), though mesenchymal
appearing cells are present.Discussion
Tbx1 and Fgf8 in cardiovascular development
A growing body of data has implicated roles for both
Tbx1 and Fgf8 during cardiac outflow tract development
and aortic arch remodeling. Mutations in either gene canresult in similar cardiovascular phenotypes, and compound
heterozygotes have more severe defects than either hetero-
zygote alone (Vitelli et al., 2002b). Both Fgf8 and Fgf10
expression levels are decreased in Tbx1-deficient embryos,
suggesting that Fgf signaling functions downstream of Tbx1
(Frank et al., 2002; Vitelli et al., 2002b). Here, we provide
direct evidence that inactivation of Fgf8 in Tbx1-expressing
cells results in DiGeorge-like cardiovascular defects. These
abnormalities are associated with a striking defect in smooth
muscle differentiation. Arterial smooth muscle is derived
from different embryonic origins. Smooth muscle of the
aortic arch and ductus arteriosus is derived from neural crest
cells (Jiang et al., 2000; Li et al., 2000). Smooth muscle of
the proximal aorta, pulmonary trunk, and descending aorta
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our Tbx1-CreDFgf8flox/  embryos are not restricted to the
neural crest-derived portions of the aortic arch. This indi-
cates that smooth muscle differentiation in the aortic arches
is dependent on the source and proximity of Fgf8 expres-
sion. Our results argue that endodermal Fgf8 expression is
required for smooth muscle differentiation in proximal aorta
and pulmonary trunk. Due to the absence of aortic arch
interruptions, which are present in Fgf8 hypomorphs (Abu-
Issa et al., 2002), we propose that Fgf8 produced from a
non-Tbx1-regulated site, such as the ectoderm, may play a
larger role in the differentiation and maintenance of smooth
muscle populations within the arch proper. Additionally, we
observed an unexpected decrease in smooth muscle differ-
entiation in the esophagus. These observations suggest that
Fgf8 signaling plays a crucial role in the differentiation of a
broad range of pharyngeal smooth muscle. Further analysis
will provide insight into the role of Fgf8 signaling in the
maintenance and differentiation of smooth muscle in diverse
tissues and of diverse embryonic origins.
Haploinsufficiency of Tbx1 results in cardiovascular
defects that include septation outflow tract defects as well
as interruptions of the aortic arch and other abnormalities
related to inappropriate regression of aortic arch segments.
Similar malformations are seen in Fgf8 hypomorphic mutant
mice. Strikingly, however, we did not observe interruptions
of the aortic arch in our Tbx1-CreDFgf8flox/ mice. Thus,
interruptions of the aortic arch in Fgf8 hypomorphic mice
may be due to deficient Fgf8 signaling that derives from
tissues that do not express Tbx1. Consistent with this idea,
recent results suggest that inactivation of Fgf8 in pharyngeal
ectoderm results in aortic arch interruptions but not outflow
tract defects (Macatee et al., 2003). Aortic arch defects
present in Tbx1 + / mice may be caused by an unrelated
mechanism, perhaps involving Fgf10 or other signaling
pathways.
Tbx1 and the secondary heart field
Fate-mapping studies described here using Tbx1-Cre
mice indicate that this transgene is expressed by early
mesodermal derivatives in the lateral and intermediate plate,
including precursors of cardiac and smooth muscle. Somitic
derivatives, including skeletal muscle, also derive from Cre-
expressing precursors in these studies (not shown). In situ
expression analysis of endogenous Tbx1 is consistent with
early expression in these tissues followed by rapid restric-
tion to more precise cell populations early during gestation.
Early expression in a broad range of mesodermal progeni-
tors has not been previously suggested, though persistent
expression in a small population of cardiac myocytes in the
outflow tract has been reported (Vitelli et al., 2002a). Other
members of the T-box family are expressed in early meso-
derm, suggesting the likelihood of functional redundancy
(Garvey et al., 1996). For instance, T (brachyury) is one of
the earliest markers of mesoderm and is expressed by allearly mesodermal cell types (Wilson et al., 1995). Tbx5 is
expressed by cardiogenic precursors and mutations in TBX5
cause Holt–Oram syndrome, which includes cardiac mal-
formations (Li et al., 1997). It is interesting to note that
while Tbx1 and Tbx5 expression domains appear to overlap
in early cardiogenic mesoderm, the expression domains in
the heart at later time points are reciprocal (Bruneau et al.,
1999). Tbx5 is expressed in the left ventricle and atria from
the looped heart tube stage onward while our results indicate
Tbx1 progeny are predominantly restricted to the right
ventricle (Bruneau et al., 1999). It will be interesting to
determine if Tbx1 serves overlapping and/or redundant
functions with other T-box family members during early
mesoderm differentiation, and how these functions may
change in the specification of cardiac cell fates later in
development.
We were surprised by the pattern and extent of cardiac
myocyte derivation from Tbx1-expressing precursors. At
the cardiac crescent stage, we identified Tbx1-Cre derived
cells in the region of cardiomyogenic precursors, and Tbx1
expression itself partially overlapped with that of Nkx2.5.
Shortly thereafter, Tbx1-Cre-derived cells populated the
pharyngeal region, the outflow tract of the heart, and
subsequently the right ventricle. This pattern of expression
is highly reminiscent of the recently described secondary or
anterior heart field (Kelly and Buckingham, 2002; Kelly et
al., 2001; Waldo et al., 2001). All or most cardiac myo-
cytes had been thought to arise from the primary heart
field, which is identified by early expression of Nkx2.5 and
other early cardiac markers. However, recent data suggests
that portions of the outflow tract and right ventricle may
arise from a secondary field located more anteriorly. The
extent of contribution of this secondary heart field to the
mature heart remains controversial, and may vary between
species. Our data suggests that the secondary heart field
may be identified by expression of Tbx1 and may originate
near the cardiac crescent. The extent of contribution to the
mature heart could depend on the precise markers used to
differentiate the two heart fields within a region that
initially represents a continuum of adjacent tissue. Hence,
at the cardiac crescent stage, Nkx2.5 may label both heart
fields, while Tbx1 is predominantly restricted to a subpop-
ulation of precursors destined to be the secondary heart
field.
Our results would argue for a significant contribution of
Tbx1-expressing precursors to both the right and left ven-
tricles. Intriguingly, the contribution of Tbx1 progeny to the
myocardium appears to increase as the heart develops. This
increase in myocardial chimerism as cardiac development
proceeds may reflect displacement of cells from the primary
heart field by cells of the secondary heart field. This would
imply a much more invasive role for cells of the secondary
heart field than has been previously noted. Labeled cells
appear in the left ventricular myocardium after it is formed
and are not simply added to the heart sequentially from a
population of pharyngeal mesoderm. Alternatively, the early
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increases in chimerism over time is therefore due to clonal
expansion of individual cells of different embryonic origin.
Given the early mesodermal expression of Tbx1 and its later
expression in pharyngeal tissues, it will be of interest to
determine which cardiac precursor populations express Tbx1
and if it plays a functional role in cardiac muscle maturation.
In this regard, it is noteworthy that some mouse models of
DiGeorge syndrome have a thinned and poorly developed
myocardium (Merscher et al., 2001). Hence, some aspects
of the Tbx1-deficient phenotype and DiGeorge syndrome
could be related to a cell-autonomous role of Tbx1 in cardiac
and other mesodermal progenitors.
Tbx1 and DiGeorge syndrome
Although TBX1 is an attractive candidate gene for
cardiovascular defects in DiGeorge syndrome, no missense
mutations have been discovered in patients with congenital
heart disease or DiGeorge syndrome who do not have
deletions on 22q11 (Han et al., 2001). If TBX1 deficiency
alone is responsible for cardiovascular malformations in this
syndrome, it is surprising that mutations in the coding
region have not been identified. It is possible that deletion
of small regions on chromosome 22 results in inactivation of
TBX1 in addition to another gene that contributes to the
phenotype or compensates for otherwise lethal effects of
TBX1 mutation (Guris et al., 2001; Yamagishi et al., 1999).
If so, hypomorphic mutations in TBX1 will possibly be
associated with congenital cardiac disorders. Additionally,
both over- and under- expression of Tbx1 in mice results in
cardiovascular malformations (Merscher et al., 2001). Muta-
tions within specific regulatory regions might reduce, or
expand, TBX1 gene expression in critical tissues resulting in
developmental defects in the absence of coding mutations.
Therefore, it is noteworthy that the enhancer regions that we
have identified are generally conserved between mouse and
human. It will be of interest to determine if mutations in
these regulatory regions are found in human cases of non-
deleted DiGeorge syndrome or in other cases of congenital
heart disease.
The observation that inactivation of Fgf8 in the Tbx1
expression domain recapitulates some, but not all, of the
cardiovascular manifestations of DiGeorge syndrome is
consistent with a role for Fgf8 downstream of Tbx1. This
interpretation is supported by prior data that indicates down-
regulation of Fgf8 in embryos lacking Tbx1, but additional
studies will be required to determine if Fgf8 is a direct
downstream transcriptional target of Tbx1. However, our
data suggests that additional targets of Tbx1 must also
function during cardiovascular development since some
characteristic malformations, including interruptions of the
aortic arch, were not seen in our studies. Likewise, the
presence of a complete array of DiGeorge-like cardiovas-
cular malformations in Fgf8 hypomorphs, which are not
recapitulated entirely by tissue-specific inactivation of Fgf8in Tbx1-expressing cells, indicates that there are mecha-
nisms unrelated to Tbx1 function that can result in the
DiGeorge cardiovascular phenotype.Acknowledgments
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